Efficacy of High-Dose Melatonin in Alleviating Radiotherapy-Induced Fatigue in Breast Cancer Patients: A Randomized Phase II Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07865988

Title field or adapter rule

{'original_value': 'Efficacy of High-Dose Melatonin in Alleviating Radiotherapy-Induced Fatigue in Breast Cancer Patients: A Randomized Phase II Trial', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-30T23:06:06.007694+00:00

Published At

2026-10-13T00:00:00+00:00

Record Updated At

2026-10-13

Source Retrieved At

2026-10-30T22:14:44.967246+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Breast Cancer", "Radiotherapy Induced Fatigue"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-13", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07865988"

protocolSection.identificationModule.officialTitle

"Efficacy of High-Dose Melatonin in Alleviating Radiotherapy-Induced Fatigue in Breast Cancer Patients: A Randomized Phase II Trial"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2", "PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Breast Cancer (protocolSection.conditionsModule.conditions)
• Radiotherapy Induced Fatigue (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Melatonin Group'], 'description': 'for melatonin group (experimental) :Oral administration of 15 mg melatonin 30-60 min before bedtime on Day 1 of radiotherapy and continuing until 1 week post-completion of the final fraction (including the boost)', 'name': 'Melatonin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Placebo Group'], 'description': 'Oral administration of an identical-appearing capsule containing microcrystalline cellulose 30-60 min before bedtime on Day 1 of radiotherapy and continuing until 1 week post-completion of the final fraction (including the boost)', 'name': 'Placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Melatonin (protocolSection.armsInterventionsModule.interventions[].name)
• Placebo (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.